anti-sars-cov-2 igg elisa (EUROIMMUN)
90
Structured Review
EUROIMMUN
anti-sars-cov-2 igg elisa
Anti Sars Cov 2 Igg Elisa, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibodies+rabbit+polyclonal+antibody+against+sars+cov+2+sp+rbd+sino+biological/anti+sars+cov+2+elisa++igg+/pmc07343640-82-11-15
Average 90 stars, based on 1 article reviews
Anti Sars Cov 2 Igg Elisa, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibodies+rabbit+polyclonal+antibody+against+sars+cov+2+sp+rbd+sino+biological/anti+sars+cov+2+elisa++igg+/pmc07343640-82-11-15
Average 90 stars, based on 1 article reviews
anti-sars-cov-2 igg elisa - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Polymerase Chain Reaction:Article Title: Detection of pre-existing neutralizing Antibodies against Ad26 in HIV-1-infected Individuals not responding to the Ad26.COV2.S Vaccine Article Snippet: Article Title: SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study Article Snippet: A commercial Article Title: Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022 Article Snippet: All serum samples were first screened using the commercial kit Article Title: Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed families Article Snippet: Samples were also analyzed using four commercially available Article Title: Inflammation-associated gut microbiome in post-acute sequelae of SARS-CoV-2 points towards new therapeutic targets Article Snippet: Participants were confirmed SARS-CoV-2 PCR positive either by nasopharyngeal swab during the acute phase of infection or by SARS-CoV-2 IgG ELISA performed per manufacturer protocols ( Article Title: Inflammation-associated gut microbiome in post-acute sequelae of SARS-CoV-2 points towards new therapeutic targets Article Snippet: Participants were confirmed SARS-CoV-2 PCR positive either by nasopharyngeal swab during the acute phase of infection or by SARS-CoV-2 IgG ELISA performed per manufacturer protocols ( Article Title: BM study: a monocentric prospective observational cohort study on neonatal humoral immunity against COVID-19 secondary to transplacental antibody transfer and breastfeeding. Article Snippet: Samples were analyzed via ELISA to quantify IgG antibodies against the Article Title: Detection of pre-existing neutralizing Antibodies against Ad26 in HIV-1-infected Individuals not responding to the Ad26.COV2.S Vaccine Article Snippet: R: Infection:Article Title: Detection of pre-existing neutralizing Antibodies against Ad26 in HIV-1-infected Individuals not responding to the Ad26.COV2.S Vaccine Article Snippet: Article Title: SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study Article Snippet: A commercial Article Title: Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022 Article Snippet: All serum samples were first screened using the commercial kit Article Title: Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed families Article Snippet: Samples were also analyzed using four commercially available Article Title: Inflammation-associated gut microbiome in post-acute sequelae of SARS-CoV-2 points towards new therapeutic targets Article Snippet: Participants were confirmed SARS-CoV-2 PCR positive either by nasopharyngeal swab during the acute phase of infection or by SARS-CoV-2 IgG ELISA performed per manufacturer protocols ( Article Title: Inflammation-associated gut microbiome in post-acute sequelae of SARS-CoV-2 points towards new therapeutic targets Article Snippet: Participants were confirmed SARS-CoV-2 PCR positive either by nasopharyngeal swab during the acute phase of infection or by SARS-CoV-2 IgG ELISA performed per manufacturer protocols ( Article Title: BM study: a monocentric prospective observational cohort study on neonatal humoral immunity against COVID-19 secondary to transplacental antibody transfer and breastfeeding. Article Snippet: Samples were analyzed via ELISA to quantify IgG antibodies against the Article Title: Detection of pre-existing neutralizing Antibodies against Ad26 in HIV-1-infected Individuals not responding to the Ad26.COV2.S Vaccine Article Snippet: R: Enzyme-linked Immunosorbent Assay:Article Title: Detection of pre-existing neutralizing Antibodies against Ad26 in HIV-1-infected Individuals not responding to the Ad26.COV2.S Vaccine Article Snippet: Article Title: SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study Article Snippet: A commercial Article Title: Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022 Article Snippet: All serum samples were first screened using the commercial kit Article Title: Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed families Article Snippet: Samples were also analyzed using four commercially available Article Title: Inflammation-associated gut microbiome in post-acute sequelae of SARS-CoV-2 points towards new therapeutic targets Article Snippet: Participants were confirmed SARS-CoV-2 PCR positive either by nasopharyngeal swab during the acute phase of infection or by SARS-CoV-2 IgG ELISA performed per manufacturer protocols ( Article Title: Inflammation-associated gut microbiome in post-acute sequelae of SARS-CoV-2 points towards new therapeutic targets Article Snippet: Participants were confirmed SARS-CoV-2 PCR positive either by nasopharyngeal swab during the acute phase of infection or by SARS-CoV-2 IgG ELISA performed per manufacturer protocols ( Article Title: BM study: a monocentric prospective observational cohort study on neonatal humoral immunity against COVID-19 secondary to transplacental antibody transfer and breastfeeding. Article Snippet: Samples were analyzed via ELISA to quantify IgG antibodies against the Article Title: Detection of pre-existing neutralizing Antibodies against Ad26 in HIV-1-infected Individuals not responding to the Ad26.COV2.S Vaccine Article Snippet: R: |